Skip to content
Therapeutic Candidates
Conditions
About
Investors
News
Forward Looking Statement
Code of Conduct
Legal Notice
Privacy Policy
Contact
Forward Looking Statement
Code of Conduct
Legal Notice
Privacy Policy
Contact
© 2025 Anavex Life Sciences Corp. All Rights Reserved.
Therapeutic Candidates
ANAVEX® 3-71
Blarcamesine (ANAVEX® 2-73)
ANAVEX® 1-41
SIGMACEPTOR
Conditions
Alzheimer’s Disease
Angelman Syndrome
Depression
Fragile X Syndrome
Frontotemporal Dementia
Infantile Spasms
Pain
Parkinson’s Disease
Rett Syndrome
Stroke
About
Events
Team
Careers
Investors
Share Data
Investor Materials
Analyst Coverage
Corporate Governance
News
Therapeutic Candidates
ANAVEX® 3-71
Blarcamesine (ANAVEX® 2-73)
ANAVEX® 1-41
SIGMACEPTOR
Conditions
Alzheimer’s Disease
Angelman Syndrome
Depression
Fragile X Syndrome
Frontotemporal Dementia
Infantile Spasms
Pain
Parkinson’s Disease
Rett Syndrome
Stroke
About
Events
Team
Careers
Investors
Share Data
Investor Materials
Analyst Coverage
Corporate Governance
News
Subscribe
Events and Presentations
Explore our presentations and engagements with the global scientific and investment communities.
January 13-16, 2025
San Francisco, CA
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
The J.P. Morgan Health Care Conference is a leading global event that brings together health care industry leaders, innovators, and investors to explore the latest advancements, trends, and opportunities shaping the future of the sector.
Learn More